The Enterprise Value as of November 2024 (TTM) for GT Biopharma, Inc. (GTBP) is 4.14M

According to GT Biopharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.14M. This represents a change of -27.36% compared to the average of 5.69M of the last 4 quarters.

GT Biopharma, Inc. (GTBP) Historical Enterprise Value (quarterly & annually)

How has GTBP Enterprise Value performed in the past?

The mean historical Enterprise Value of GT Biopharma, Inc. over the last ten years is 361.57M. The current 4.14M Enterprise Value has changed 14.38% with respect to the historical average. Over the past ten years (40 quarters), GTBP's Enterprise Value was at its highest in in the June 2021 quarter at 15.55B. The Enterprise Value was at its lowest in in the June 2024 quarter at 1.87M.

GT Biopharma, Inc. (GTBP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of GT Biopharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

GT Biopharma, Inc. (GTBP) Average Enterprise Value

How has GTBP Enterprise Value performed in the past?

The current Enterprise Value of GT Biopharma, Inc. (GTBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

GT Biopharma, Inc. (GTBP) Enterprise Value vs. Peers

How is GTBP’s Enterprise Value compared to its peers?

GT Biopharma, Inc.’s Enterprise Value is greater than Allarity Therapeutics, Inc. (-15916163.00), greater than NeuroBo Pharmaceuticals, Inc. (-6292396.00), greater than Hillstream BioPharma, Inc. (1.48M), less than Virax Biolabs Group Limited (5.49M), greater than Quoin Pharmaceuticals, Ltd. (3.24M), less than Panbela Therapeutics, Inc. (5.93M), greater than Virpax Pharmaceuticals, Inc. (1.60M), greater than Revelation Biosciences, Inc. (-8886223.00), greater than Biodexa Pharmaceuticals Plc (-2510386.26), less than Praxis Precision Medicines, Inc. (1.10B), greater than Pulmatrix, Inc. (-6183620.00), less than Oncorus, Inc. (51.18M), less than Akari Therapeutics, Plc (26.33M), greater than Sonnet BioTherapeutics Holdings, Inc. (-448232.00), less than Landos Biopharma, Inc. (42.62M), less than Cingulate Inc. (11.61M), less than SAB Biotherapeutics, Inc. (25.39M), less than Anebulo Pharmaceuticals, Inc. (45.92M), less than Cadrenal Therapeutics, Inc. Common Stock (10.21M), less than Monopar Therapeutics Inc. (81.10M), greater than Protara Therapeutics, Inc. (-31165818.00), less than Vaccinex, Inc. (8.95M), less than Miromatrix Medical Inc. (90.06M), greater than Surrozen, Inc. (2.49M),

Build a custom stock screener for GT Biopharma, Inc. (GTBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GT Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

GT Biopharma, Inc. (GTBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like GT Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.